Immunic, Inc. (IMUX) Balance Sheet
IMUX balance sheet, 2025
December 31, 2025 · U.S. dollars$24.1M assets = $30.7M liabilities + −$6.7M equity
Liabilities exceed assets: shareholders’ equity is negative (−$6.7M).
Both columns are drawn to the same scale: what IMUX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
IMUX financial health
Descriptive bands, not a rating. Fiscal 2025.
IMUX balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $64.0M2016 | $24.1M2025 | −10.3%/yr | |
| Total liabilities | $5.6M2016 | $30.7M2025 | +20.9%/yr | |
| Shareholders’ equity | $58.4M2016 | −$6.7M2025 | — | |
| Cash & short-term investments | $60.0M2016 | $15.5M2025 | −14.0%/yr | |
| Total debt | $02016 | $684,0002025 | — | |
| Net cash (debt) | $60.0M2016 | $14.8M2025 | −$45.2M | |
| Working capital | $56.0M2016 | −$7.7M2025 | −$63.7M | |
| Book value per share | $35.732022 | −$0.432025 | — | |
| Current ratio | 11.222016 | 0.752025 | −10.47 | |
| Debt / equity | 0.002016 | 0.052024 | +0.05 | |
| Shares outstanding | 3.2M2022 | 15.6M2025 | +69.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
IMUX assets
IMUX liabilities and equity
IMUX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
IMUX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $15.5M | $35.7M | $46.7M | $116.4M | $86.9M | $127.5M | $29.4M | $13.3M | $56.9M | $60.0M |
| Cash & equivalents | $15.5M | $35.7M | $46.7M | $106.7M | $86.9M | $127.5M | $29.4M | $13.3M | $56.9M | $60.0M |
| Short-term investments | — | — | $0 | $9.6M | $0 | — | — | — | $0 | $0 |
| Receivables | $4.1M | $684,000 | $703,000 | $296,000 | $2.1M | $295,000 | $408,000 | $191,000 | $0 | $541,521 |
| Inventory | $0 | $0 | $0 | $5.6M | −$2.1M | $3.4M | −$408,000 | −$191,000 | $0 | $0 |
| Other current assets | $3.3M | $3.0M | $5.2M | $3.6M | $18.1M | $2.6M | $2.9M | $908,000 | $1.2M | $930,479 |
| Total current assets | $22.9M | $39.3M | $52.5M | $125.9M | $105.0M | $133.7M | $32.2M | $14.2M | $58.1M | $61.5M |
| Property, plant & equipment (net) | $1.2M | $1.5M | $1.8M | $1.8M | $1.1M | $1.1M | $713,000 | $709,000 | $2.2M | $2.5M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $65.9M | $65.9M | $65.9M | $0 | $2.7M | $3.1M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $43,000 | $0 | $0 | $0 | $37,000 | $0 | $0 |
| Total assets | $24.1M | $40.9M | $54.3M | $127.8M | $139.1M | $167.9M | $66.0M | $15.0M | $60.4M | $64.0M |
| Liabilities | ||||||||||
| Accounts payable | $10.1M | $7.8M | $5.1M | $4.3M | $3.5M | $3.7M | $2.4M | $268,000 | $1.0M | $780,000 |
| Short-term debt | $470,000 | $740,000 | $695,000 | $571,000 | $408,000 | $297,000 | $3.3M | — | $0 | $0 |
| Deferred revenue | — | — | — | — | $6.7M | −$297,000 | $1.0M | — | — | — |
| Total current liabilities | $30.6M | $22.2M | $24.7M | $13.1M | $11.4M | $8.4M | $7.1M | $2.5M | $10.3M | $5.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $577,000 | $1.0M | $1.3M | $1.6M | $584,000 | $679,000 | $520,000 | — | — | — |
| Other long-term liabilities | $107,000 | $264,000 | $639,000 | $992,000 | $584,000 | $679,000 | $520,000 | $41,000 | $59,000 | $100,000 |
| Total liabilities | $30.7M | $22.4M | $25.4M | $14.1M | $12.0M | $9.1M | $7.6M | $2.6M | $10.3M | $5.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $9,000 | $8,000 | $4,000 | $4,000 | $3,000 | $2,000 | $1,000 | $4,000 | $4,000 | $3,000 |
| Retained earnings (deficit) | −$608.6M | −$511.4M | −$410.9M | −$317.3M | −$196.9M | −$103.9M | −$59.9M | −$337.4M | −$296.0M | −$243.8M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | $2.6M | $4.2M | $3.8M | $3.0M | −$252,000 | −$4.1M | −$1.4M | $80,000 | $78,000 | $83,000 |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | −$6.7M | $18.4M | $28.9M | $113.7M | $127.1M | $158.8M | $58.4M | $12.4M | $50.0M | $58.4M |
| Key figures | ||||||||||
| Total debt | $684,000 | $1.0M | $1.3M | $1.6M | $992,000 | $976,000 | $520,000 | $37.2M | $0 | $0 |
| Net cash (debt) | $14.8M | $34.7M | $45.3M | $114.8M | $85.9M | $126.5M | $28.8M | −$23.9M | $56.9M | $60.0M |
| Working capital | −$7.7M | $17.2M | $27.8M | $112.8M | $93.6M | $125.3M | $25.2M | $11.7M | $47.8M | $56.0M |
| Tangible book value | −$6.7M | $18.4M | $28.9M | $113.7M | $61.2M | $92.8M | −$7.6M | $12.4M | $47.3M | $55.4M |
| Book value per share | −$0.43 | $1.84 | $6.53 | $35.73 | — | — | — | — | — | — |
| Shares outstanding | 15.6M | 10.0M | 4.4M | 3.2M | — | — | — | — | — | — |
| Current ratio | 0.75 | 1.77 | 2.12 | 9.62 | 9.21 | 15.93 | 4.56 | 5.67 | 5.65 | 11.22 |
| Quick ratio | 0.64 | 1.64 | 1.92 | 8.92 | 7.81 | 15.21 | 4.21 | 5.38 | 5.53 | 11.05 |
| Debt / equity | — | 0.05 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 | 2.99 | 0.00 | 0.00 |
| Equity / assets | −27.7% | 45.1% | 53.3% | 89.0% | 91.4% | 94.6% | 88.5% | 83.0% | 82.9% | 91.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $155.1M | $186.6M | $15.5M | $35.1M | $55.3M | $14.3M | $35.7M | $59.1M | $79.7M | $97.3M | $46.7M | $59.7M |
| Cash & equivalents | $155.1M | $186.6M | $15.5M | $35.1M | $55.3M | $14.3M | $35.7M | $59.1M | $79.7M | $97.3M | $46.7M | $59.7M |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Receivables | $0 | $354,000 | $4.1M | $177,000 | $594,000 | $631,000 | $684,000 | $819,000 | $1.5M | $1.4M | $703,000 | $1.2M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.3M |
| Other current assets | $2.7M | $1.8M | $3.3M | $4.0M | $3.9M | $4.0M | $3.0M | $3.4M | $3.8M | $3.9M | $5.2M | $2.1M |
| Total current assets | $157.8M | $188.8M | $22.9M | $39.3M | $59.8M | $19.0M | $39.3M | $63.3M | $85.0M | $102.6M | $52.5M | $65.2M |
| Property, plant & equipment (net) | $1.3M | $983,000 | $1.2M | $1.4M | $1.6M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.8M | $1.7M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $43,001 |
| Total assets | $159.2M | $189.7M | $24.1M | $40.7M | $61.4M | $20.5M | $40.9M | $64.8M | $86.5M | $104.2M | $54.3M | $67.0M |
| Liabilities | ||||||||||||
| Accounts payable | $12.7M | $10.5M | $10.1M | $7.3M | $7.9M | $5.5M | $7.8M | $5.8M | $7.6M | $6.2M | $5.1M | $3.2M |
| Short-term debt | $239,000 | $275,000 | $470,000 | $666,000 | $774,000 | $765,000 | $740,000 | $713,000 | $714,000 | $697,000 | $695,000 | $662,000 |
| Deferred revenue | — | — | — | — | — | — | — | — | — | — | — | $14.0M |
| Total current liabilities | $31.3M | $38.4M | $30.6M | $30.1M | $27.3M | $25.6M | $22.2M | $23.4M | $22.7M | $20.1M | $24.7M | $17.8M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $567,000 | $421,000 | $577,000 | $792,000 | $979,000 | $975,000 | $1.0M | $899,000 | $955,000 | $1.1M | $1.3M | $1.5M |
| Other long-term liabilities | $328,000 | $146,000 | $107,000 | $125,999 | $205,000 | $210,000 | $264,000 | $186,000 | $241,000 | $433,000 | $639,000 | $789,000 |
| Total liabilities | $31.6M | $38.5M | $30.7M | $30.2M | $27.5M | $25.8M | $22.4M | $23.5M | $22.9M | $20.6M | $25.4M | $18.6M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $13,000 | $11,000 | $9,000 | $9,000 | $9,000 | $8,000 | $8,000 | $8,000 | $8,000 | $8,000 | $4,000 | $4,000 |
| Retained earnings (deficit) | −$675.3M | −$641.2M | −$608.6M | −$589.3M | −$563.7M | −$536.9M | −$511.4M | −$486.2M | −$461.9M | −$440.5M | −$410.9M | −$389.3M |
| Accumulated other comprehensive income | $2.8M | $3.1M | $2.6M | $2.6M | $2.5M | $3.9M | $4.2M | $3.9M | $3.8M | $4.3M | $3.8M | $3.9M |
| Total shareholders' equity | $127.6M | $151.2M | −$6.7M | $10.5M | $33.9M | −$5.3M | $18.4M | $41.2M | $63.6M | $83.6M | $28.9M | $48.4M |
| Key figures | ||||||||||||
| Total debt | $567,000 | $421,000 | $684,000 | $792,000 | $979,000 | $975,000 | $1.0M | $899,000 | $955,000 | $1.1M | $1.3M | $1.5M |
| Net cash (debt) | $154.5M | $186.2M | $14.8M | $34.3M | $54.3M | $13.3M | $34.7M | $58.2M | $78.7M | $96.2M | $45.3M | $58.2M |
| Working capital | $126.6M | $150.4M | −$7.7M | $9.2M | $32.5M | −$6.6M | $17.2M | $39.9M | $62.3M | $82.5M | $27.8M | $47.5M |
| Tangible book value | $127.6M | $151.2M | −$6.7M | $10.5M | $33.9M | −$5.3M | $18.4M | $41.2M | $63.6M | $83.6M | $28.9M | $48.4M |
| Book value per share | $3.00 | $5.02 | −$0.55 | $0.54 | $2.57 | −$0.52 | $2.04 | $4.07 | $6.28 | $8.59 | $6.48 | $10.86 |
| Shares outstanding | 42.5M | 30.1M | 12.0M | 19.4M | 13.2M | 10.1M | 9.0M | 10.1M | 10.1M | 9.7M | 4.5M | 4.5M |
| Current ratio | 5.05 | 4.92 | 0.75 | 1.31 | 2.19 | 0.74 | 1.77 | 2.71 | 3.75 | 5.09 | 2.12 | 3.67 |
| Quick ratio | 4.96 | 4.87 | 0.64 | 1.17 | 2.05 | 0.58 | 1.64 | 2.56 | 3.58 | 4.90 | 1.92 | 3.42 |
| Debt / equity | 0.00 | 0.00 | — | 0.08 | 0.03 | — | 0.05 | 0.02 | 0.02 | 0.01 | 0.05 | 0.03 |
| Equity / assets | 80.2% | 79.7% | −27.7% | 25.8% | 55.2% | −25.8% | 45.1% | 63.6% | 73.5% | 80.2% | 53.3% | 72.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 26, 2026); data from EODHD.
IMUX financial position
At the end of fiscal 2025 (December 31, 2025), Immunic had total assets of $24.1 million (down 41.1% from a year earlier), total liabilities of $30.7 million and shareholders' equity of -$6.7 million. It held $15.5 million in cash and short-term investments against $0.7 million of debt, a net cash position of $14.8 million. Its current ratio was 0.75. In the latest quarter (ended June 30, 2026) total assets were $159.2 million and equity $127.6 million.
Related: IMUX income statement, IMUX cash flow statement, IMUX key metrics. See the IMUX stock overview for the latest quote and news.
IMUX balance sheet FAQ
What are Immunic's total assets?
Immunic reported total assets of $24.1 million at the end of fiscal 2025 (December 31, 2025), compared with $40.9 million a year earlier.
How much debt does Immunic have?
Immunic had $0.7 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Immunic have?
Immunic held $15.5 million in cash and short-term investments at the end of fiscal 2025; with $0.7 million of debt that is net cash of $14.8 million.
What is Immunic's book value?
Immunic's shareholders' equity (book value) was -$6.7 million at the end of fiscal 2025, or −$0.43 per share.
What is Immunic's current ratio?
Immunic had current assets of $22.9 million and current liabilities of $30.6 million, a current ratio of 0.75 (current liabilities exceed current assets).